%0 Generic
%T Cediranib, a VEGF receptor 1, 2, and 3 inhibitor, and pemetrexed in patients (pts) with recurrent non-small cell lung cancer (NSCLC)
%A Gadgeel, S. M.
%A Wozniak, A.
%A Edelman, M. J.
%A Valdivieso, M.
%A Heilbrun, L.
%A Venkatramanamoorthy, R.
%A Shields, A.
%A LoRusso, P.
%A Hackstock, D.
%A Ruckdeschel, J.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2009
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation